REGN Regeneron Pharmaceuticals

$843.50 -1.02%

Updated 16 d ago

Healthcare · Pharmaceutical Preparations

Regeneron Pharmaceuticals (REGN) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $87.2 billion. Shares last traded at $843.50, near their 52-week high. Over the past year the stock is up 45.2%. REGN trades at a price-to-earnings ratio of 20.15, above the Pharmaceutical Preparations median of 17.31. Net profit margin is 27.9%, above the peer median of -8.9%. Revenue grew 1.0% year over year. The shares yield 0.4% in dividends.

Market Cap

$87.2B

Shares Out

103.4M

EPS (TTM)

$79.33

P/E Ratio

10.63

P/S Ratio

5.61

P/B Ratio

2.75

Dividend / Share

$3.64

Dividend Yield

0.43%

52-Week High

$858.23

52-Week Low

$541.23

Volume

28,195

Avg Vol (3m)

55,392.857

Performance

+4.44%

+8.84%

+39.95%

+10.06%

YTD

+8.63%

+45.24%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

66.24

SMA (50)

$733.96

SMA (200)

$732.42

Price vs SMA50

+14.92%

Price vs SMA200

+15.17%

ATR (14)

$19.96

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$15.5B

Net Income

$4.3B

Gross Margin

—

Operating Margin

24.7%

Net Margin

27.9%

Return on Equity

13.7%

Return on Assets

10.4%

Current Ratio

3.34

Debt / Equity

0.06

Revenue Growth (YoY)

+1.0%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$18.95	2026-07-30
Q1 2026	$6.75	2026-04-29
FY 2025	$41.48	2026-02-04
Q3 2025	$33.61	2025-10-28
Q2 2026	$20.02	2026-07-30
Q1 2026	$7.27	2026-04-29

Full earnings history →

Pharmaceutical Preparations peers

REGN vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated 16 d ago

P/E vs peers

20.15 / 17.31 med

+16% premium

P/S vs peers

5.61 / 11.11 med

-49% discount

Net margin vs peers

27.9% / -8.9% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%
REGN	Regeneron Pharmaceuticals	$87.2B	20.15	5.61	27.9%	-1.02%
TEVA	Teva Pharmaceutical Industries Ltd	$42.6B	60.41	2.46	4.1%	-2.32%
ALNY	Alnylam Pharmaceuticals	$35.4B	43.77	9.52	21.8%	-1.10%
ZTS	Zoetis	$31.5B	12.05	3.31	27.5%	+0.16%
RPRX	Royalty Pharma Plc	$28.2B	34.56	11.11	32.1%	+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.